although there was a significant difference ( p equals 0.037 ) in the incidence of disease progression in patients with diploid tumors ( 13 % ) versus those with aneuploid tumors ( 35 % ) in the total population , and kaplan-meier disease-specific survival curves demonstrated a survival advantage for patients with diploid tumors in the total population , no clear survival advantage was demonstrated for evaluable patients with diploid tumors when controlled for tumor , nodes and metastases stage .
C0012634
disease
C0027651
tumor